COMMUNIQUÉS West-GlobeNewswire

Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial Results

14/02/2018 - 22:05

NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP ), a pharmaceutical company developing therapies for ophthalmic diseases, today reported financial results and operating highlights for [...]

Avid Bioservices Announces Proposed Offering of Common Stock

14/02/2018 - 22:02

TUSTIN, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ) today announced that it has commenced an underwritten public offering of its common stock. Avid Bioservices also [...]

athenahealth Provides Guidance for Fiscal Year 2018 at its Investor Summit

14/02/2018 - 22:01

WATERTOWN, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ) (“athenahealth” or “we”), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, will host [...]

Amicus Therapeutics Announces Public Offering of Common Stock

14/02/2018 - 22:01

CRANBURY, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced it has commenced a $250 million underwritten public offering of its common stock. J.P. Morgan Securities LLC and [...]

Cytokinetics to Present at the RBC Capital Markets Global Healthcare Conference

14/02/2018 - 22:00

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK ) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at [...]

Cutera Reports Fourth Quarter and Full Year 2017 Record Revenue and Financial Results

14/02/2018 - 22:00

Record Fourth Quarter Revenue of $47.6 Million; Increases 26% Year-over-Year; 14 th Consecutive Quarter of Double-Digit Revenue Growth System Revenue Grows in the Fourth Quarter by 35% in North America and 19% [...]

Veloxis Secures USD 60M in Debt Financing

14/02/2018 - 21:36

Company Release no. 01/2018 To: NASDAQ Copenhagen A/S 14 February 2018 Veloxis Secures USD 60M in Debt Financing Cary, NC, February 14, 2018 -- Veloxis Pharmaceuticals A/S (OMX:VELO), a specialty pharmaceutical company [...]

Cannabis Wheaton Income Corp. Extends Warrant Expiry Until February 20, 2018

14/02/2018 - 21:31

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V: [...]

Nextech Announces Key Expansions to Executive Team

14/02/2018 - 20:56

TAMPA, Fla., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, today announces two major updates to its executive leadership [...]

Adventist Health Announces Retirement of CFO Jack Wagner

14/02/2018 - 18:20

ROSEVILLE, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii— today announced the planned [...]

MJ Biotech, Inc Corporate Update

14/02/2018 - 18:19

CHEYENNE, Wyo., Feb. 14, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) is in the process of completing its acquisition of Zen Hero, Inc. with the expectation of closing this [...]

Envigo Announces Termination of Transaction Agreement with Avista Healthcare Public Acquisition Corp.

14/02/2018 - 17:34

EAST MILLSTONE, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Envigo International Holdings, Inc. ("Envigo"), a leading provider of nonclinical contract research services and research models, announced today that the [...]

FIT Biotech Oy: FIT Biotech Ltd's own equity negative in the end of January - Fit Biotech Ltd's own equity to positive with the draw down of a second tranche of financing

14/02/2018 - 17:23

FIT Biotech Oy Company release February 14, 2018 at 6.00 pm EET FIT Biotech Ltd's own equity negative in the end of January - Fit Biotech Ltd's own equity to positive with the draw down of a second tranche of financing [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

14/02/2018 - 16:45

FIT Biotech Oy Company release February 14, 2018 at 5:45 pm EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On December 22, 2017, the Board of Directors of FIT Biotech [...]

The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day

14/02/2018 - 16:35

WASHINGTON, D.C., Feb. 14, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today announced its annual Cell & Gene Therapy Investor Day will take place April 17, 2018 in New York City. This [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

14/02/2018 - 16:31

FIT Biotech Oy Company release February 14, 2018 at 5:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Emerald Health Therapeutics Closes $18 Million Prospectus Sale

14/02/2018 - 15:52

VICTORIA, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) ("Emerald" or the “Company”) has closed its prospectus sale (the “Offering”) to a single Canadian [...]

Tauriga Sciences Inc. Gains Exposure to Electric Vehicle Infrastructure Market Segment Through Strategic $191,250 USD Transaction

14/02/2018 - 15:40

NEW YORK, NY, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]

Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented), 0.05%

14/02/2018 - 15:31

BUENA, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]